Michael Wells
Family Medicine · Independence, MONPI 1033181367
Payments from drug & device makers
Across 340 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$648
- AstraZeneca$606
- Novo Nordisk$506
- Lilly USA, LLC$487
- Boehringer Ingelheim$461
- Pfizer$445
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,407100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $648 |
| AstraZeneca | 33 | $606 |
| Novo Nordisk | 39 | $506 |
| Lilly USA, LLC | 30 | $487 |
| Boehringer Ingelheim | 30 | $461 |
| Pfizer | 38 | $445 |
| GSK | 19 | $293 |
| Amgen | 13 | $256 |
| Vanda Pharmaceuticals Inc. | 7 | $173 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $171 |
| Astellas Pharma US Inc | 8 | $149 |
| Eisai Inc. | 8 | $135 |
| Sumitomo Pharma America, Inc. | 3 | $130 |
| Nevro Corp. | 1 | $129 |
| Biohaven Pharmaceuticals, Inc. | 3 | $122 |
| Novartis | 7 | $108 |
| Abbott | 6 | $108 |
| Merck | 7 | $88 |
| Sunovion Pharmaceuticals Inc. | 9 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $77 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $50 |
| Bayer | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Johnson & Johnson | 2 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $24 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Mylan Specialty L.p. | 2 | $22 |
| Optos, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,414 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 68 | $96,378 |
| OzempicSemaglutide | 46 | $60,010 |
| EliquisApixaban | 55 | $59,217 |
| TrulicityDulaglutide | 29 | $54,905 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $34,881 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 42 | $29,182 |
| MyrbetriqMirabegron | 30 | $25,527 |
| RybelsusSemaglutide | 16 | $24,545 |
| JanuviaSitagliptin Phosphate | 23 | $18,210 |
| XareltoRivaroxaban | 18 | $18,130 |
| Spiriva RespimatTiotropium Bromide | 11 | $13,307 |
| MounjaroTirzepatide | 12 | $12,621 |
| SymbicortBudesonide/Formoterol Fumarate | 25 | $11,437 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 288 | $8,881 |
| VascepaIcosapent Ethyl | 24 | $8,880 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Stiolto Respimat, Spiriva Respimat | $461 | $138,867121 claims |
| Novo NordiskOzempic, Rybelsus | $506 | $84,55562 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $487 | $67,52641 claims |
| PfizerEliquis | $445 | $59,21755 claims |
| GSKTrelegy Ellipta, Shingrix | $293 | $38,86741 claims |
| Astellas Pharma US IncMyrbetriq | $149 | $25,52730 claims |
| MerckJanuvia | $88 | $18,21023 claims |
| Johnson & JohnsonXarelto | $27 | $18,13018 claims |
| AstraZenecaSymbicort | $606 | $11,43725 claims |
| AbbVieSynthroid | $648 | $1,48012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Independence
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.